Headlines about scPharmaceuticals (NASDAQ:SCPH) have been trending somewhat positive this week, according to Accern. The research firm identifies negative and positive media coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. scPharmaceuticals earned a news sentiment score of 0.13 on Accern’s scale. Accern also gave headlines about the company an impact score of 47.4606463307841 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

scPharmaceuticals (NASDAQ SCPH) traded down $0.09 during mid-day trading on Monday, reaching $14.07. The company had a trading volume of 24,600 shares, compared to its average volume of 247,900. scPharmaceuticals has a 12-month low of $13.78 and a 12-month high of $14.94.

In related news, major shareholder 5Am Partners Iv, Llc bought 654,762 shares of scPharmaceuticals stock in a transaction that occurred on Tuesday, November 21st. The shares were purchased at an average price of $14.00 per share, with a total value of $9,166,668.00. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

WARNING: This piece was reported by Watch List News and is the sole property of of Watch List News. If you are viewing this piece on another publication, it was stolen and republished in violation of US and international copyright law. The correct version of this piece can be read at https://www.watchlistnews.com/somewhat-positive-news-coverage-somewhat-unlikely-to-affect-scpharmaceuticals-scph-stock-price/1729641.html.

scPharmaceuticals Company Profile

scPharmaceuticals, Inc, is a biopharmaceutical company. The Company is engaged in developing pharmaceutical products for subcutaneous delivery. The Company offers sc2Wear Infusor, which is a small pump that attaches to the body using a standard medical adhesive. The sc2Wear Infusor injects the drug into the body slowly, similar to an intravenous (IV) drip.

Receive News & Ratings for scPharmaceuticals Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for scPharmaceuticals Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.